Product Datasheet
|
|
|
Product Description |
|
Product: |
RBD of SARS-CoV-2 Spike Protein, His tag |
Catalog Number: |
RBD-HIS |
Product Page: |
https://www.mol-innov.com/products/ICOV2RBDRHIS50UG |
Description: |
SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein binds to the cell receptor ACE2 allowing viral entry and infection. It is a 223 amino acid glycoprotein representing residues 319-541 of the spike protein S1 sequence. RBD from Molecular Innovations is useful for capturing SARS-CoV-2 specific antibodies from human plasma and serum in COVID-19 serological assays. Recombinantly produced in HEK cell culture and purified by chelated metal affinity chromatography. Contains a 6X-Histidine tag at C terminus for purification.
Produced under license from the Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
185.50 |
Source: |
0.25 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
25,900 |
Antigen: |
-70 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
COVID-19 |
Host: |
297.5 |
Clonality: |
30 |
Isotype: |
Human Embryonic Kidney cells
|
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery
|
|
Sample Characteristics |
|
Lot Number: |
RBD-HIS-ICOV2RBDRHIS100UG |
Aliquot: |
1 x SARS-CoV-2 Spike Protein RBD Recombinant HIS Labeled 100ug |
Concentration: |
265 |
Volume: |
425 |
Titer: |
PBS |
Buffer: |
SAMPLE |
Form: |
0.05 mg |
Preservative: |
0.2 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |